Over the last 7 days, the Pharma industry has dropped 1.2%, driven by a pullback from Merck of 5.3%. Over the past 12 months, the industry was up 18%. Looking forward, earnings are forecast to grow by 27% annually.
Has the U.S. Pharma Industry valuation changed over the past few years?
Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
---|---|---|---|---|---|---|
Mon, 01 Jul 2024 | US$1.9t | US$357.6b | US$13.8b | 16.1x | 140.9x | 5.4x |
Wed, 29 May 2024 | US$1.9t | US$358.3b | US$14.1b | 16x | 133.3x | 5.2x |
Fri, 26 Apr 2024 | US$1.8t | US$359.5b | US$17.5b | 21.9x | 101.6x | 5x |
Sun, 24 Mar 2024 | US$1.9t | US$355.3b | US$22.6b | 19.8x | 82.6x | 5.3x |
Tue, 20 Feb 2024 | US$1.9t | US$355.0b | US$23.9b | 28.3x | 79.4x | 5.4x |
Thu, 18 Jan 2024 | US$1.8t | US$375.2b | US$33.9b | 27.6x | 51.7x | 4.7x |
Sat, 16 Dec 2023 | US$1.6t | US$375.1b | US$33.9b | 26.7x | 48.6x | 4.4x |
Mon, 13 Nov 2023 | US$1.6t | US$375.5b | US$34.1b | 26.5x | 47.6x | 4.3x |
Wed, 11 Oct 2023 | US$1.7t | US$381.8b | US$43.8b | 18.1x | 38.6x | 4.4x |
Fri, 08 Sep 2023 | US$1.8t | US$381.8b | US$43.9b | 19.3x | 41.3x | 4.7x |
Sun, 06 Aug 2023 | US$1.7t | US$379.8b | US$43.1b | 21.5x | 39.1x | 4.4x |
Tue, 04 Jul 2023 | US$1.7t | US$392.8b | US$60.2b | 18.6x | 29x | 4.4x |
Thu, 01 Jun 2023 | US$1.7t | US$393.0b | US$60.6b | 17.8x | 27.7x | 4.3x |
Sat, 29 Apr 2023 | US$1.7t | US$400.2b | US$62.2b | 17.4x | 27x | 4.2x |
Mon, 27 Mar 2023 | US$1.6t | US$401.2b | US$69.5b | 14.7x | 22.3x | 3.9x |
Wed, 22 Feb 2023 | US$1.6t | US$401.7b | US$68.4b | 17.9x | 23.6x | 4x |
Fri, 20 Jan 2023 | US$1.7t | US$403.7b | US$70.6b | 17.7x | 23.9x | 4.2x |
Sun, 18 Dec 2022 | US$1.7t | US$403.7b | US$70.7b | 16.7x | 24.6x | 4.3x |
Tue, 15 Nov 2022 | US$1.7t | US$403.6b | US$71.1b | 12.9x | 24x | 4.2x |
Thu, 13 Oct 2022 | US$1.6t | US$403.0b | US$71.3b | 12.2x | 21.8x | 3.9x |
Sat, 10 Sep 2022 | US$1.6t | US$403.0b | US$71.3b | 14x | 22.5x | 4x |
Mon, 08 Aug 2022 | US$1.6t | US$403.3b | US$69.5b | 19.3x | 23.5x | 4.1x |
Wed, 06 Jul 2022 | US$1.7t | US$392.4b | US$65.1b | 22.1x | 26x | 4.3x |
Fri, 03 Jun 2022 | US$1.7t | US$392.5b | US$64.8b | 21.5x | 25.7x | 4.2x |
Sun, 01 May 2022 | US$1.6t | US$380.0b | US$61.3b | 20.5x | 26.7x | 4.3x |
Tue, 29 Mar 2022 | US$1.7t | US$373.8b | US$60.4b | 22.2x | 27.4x | 4.4x |
Thu, 24 Feb 2022 | US$1.5t | US$373.4b | US$59.2b | 20.8x | 25.4x | 4x |
Sat, 22 Jan 2022 | US$1.6t | US$361.3b | US$37.7b | 22.8x | 41.4x | 4.3x |
Mon, 20 Dec 2021 | US$1.6t | US$361.1b | US$38.1b | 22.6x | 42.9x | 4.5x |
Wed, 17 Nov 2021 | US$1.6t | US$360.6b | US$38.5b | 24.1x | 41.4x | 4.4x |
Fri, 15 Oct 2021 | US$1.5t | US$337.7b | US$24.8b | 21.6x | 60x | 4.4x |
Sun, 12 Sep 2021 | US$1.5t | US$338.7b | US$25.4b | 18.4x | 60.1x | 4.5x |
Tue, 10 Aug 2021 | US$1.6t | US$338.5b | US$25.8b | 21.9x | 61.7x | 4.7x |
73.2x
Which industries have driven the changes within the U.S. Healthcare industry?
US Market | -0.06% | |
Healthcare | -0.85% | |
Pharma | -1.16% | |
Pharma | -1.16% |
Which companies have driven the market over the last 7 days?
Company | Last Price | 7D | 1Y | Valuation | |
---|---|---|---|---|---|
LLY Eli Lilly | US$905.38 | 1.7% +US$13.7b | 96.2% | PE132.8x | |
ZTS Zoetis | US$173.36 | 0.9% +US$693.6m | 1.8% | PE33.1x | |
LBPH Longboard Pharmaceuticals | US$27.03 | 29.9% +US$241.8m | 268.3% | PB3.4x | |
CORT Corcept Therapeutics | US$32.49 | 6.2% +US$197.8m | 46.9% | PE28.9x | |
VTRS Viatris | US$10.63 | 1.5% +US$190.5m | 7.5% | PS0.8x |